Habener led research that discovered the GLP-1 hormone, a key ingredient in Ozempic and Mounjaro. ......
Vous n'êtes pas connecté
Maroc - Times of India - Life & Style - 13/12/2024 17:13
Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass, and combined with a GLP-1 agonist like Ozempic, increased it by 700%. The team discovered that alpha cells could potentially be transformed into beta cells, offering a new source for insulin production.
Habener led research that discovered the GLP-1 hormone, a key ingredient in Ozempic and Mounjaro. ......
Scientists have discovered a new gene linked to neonatal diabetes. This gene, TMEM167A, affects insulin-producing cells in infants. It also impacts...
PHILADELPHIA, Dec. 17, 2025 (GLOBE NEWSWIRE) — The U.S. Judicial Panel on Multidistrict Litigation has ordered the creation of a new federal...
PHILADELPHIA, Dec. 17, 2025 (GLOBE NEWSWIRE) — The U.S. Judicial Panel on Multidistrict Litigation has ordered the creation of a new federal...
The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the...
The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the...
Mitochondria are small structures inside our cells that make energy. This energy helps cells do their jobs. When mitochondria don’t work properly,...
Highlights: FDA approves oral semaglutide as the first GLP-1 pill for weight loss Once-daily tablet offers compa
Highlights: FDA approves oral semaglutide as the first GLP-1 pill for weight loss Once-daily tablet offers compa
FDA approves oral semaglutide, the first GLP-1 weight-loss pill, offering effective obesity treatment with cardiovascular protection-no injections...